Table 3: Main results from the SPRINT study. |
|||||||
Variable |
Intensive treatment, % |
Standard treatment, % |
Hazard ratio |
RRR, % |
p |
RAR, % |
NNT |
Primary outcome |
5.2 |
6.8 |
0.75 |
25 |
< 0.001 |
1.6 |
62 |
Death from any cause |
3.3 |
4.5 |
0.73 |
27 |
0.003 |
1.2 |
83 |
Death from CV cause |
0.8 |
1.4 |
0.43 |
57 |
0.005 |
0.6 |
166 |
Heart failure |
1.3 |
2.1 |
0.62 |
38 |
0.002 |
0.8 |
125 |
Primary outcome or death |
7.1 |
9 |
0.78 |
22 |
< 0.001 |
1.9 |
52 |
Complications |
Intensive treatment, % |
Standard treatment, % |
Hazard ratio |
IRR, % |
p |
IAR, % |
NNH |
Hypotension |
2.4 |
1.4 |
1.70 |
70 |
0.001 |
1 |
100 |
Acute kidney injury |
4.4 |
2.6 |
1.69 |
69 |
0.001 |
1.8 |
55 |
Syncope |
3.5 |
2.4 |
1.45 |
45 |
0.003 |
1.1 |
90 |
30% ↓ eGFR in patients without CKD |
3.8 |
1.1 |
3.45 |
345 |
0.001 |
2.7 |
37 |
RRR = reduction of relative risk. RAR = reduction of absolute risk. IRR = increment of relative risk. IAR = increment of absolute risk. NNT = number needed to treat. NNH = number needed to harm. Although consistent, there are small variations between these estimates and those provided by the authors in the original article. |